Guanajuato Silver completes Bolanitos mine acquisition to strengthen district-scale gold and silver operations
Guanajuato Silver completes the Bolanitos mine acquisition, reinforcing its district-scale gold and silver strategy in Mexico. Find out what this means for growth and sentiment.
Sila Realty Trust expands healthcare real estate footprint with $43.1m inpatient rehab facility buy in Oklahoma City
Find out how Sila Realty Trust’s $43.1 million acquisition of an oklahoma city inpatient rehabilitation facility strengthens its healthcare real estate portfolio and income strategy.
SunPower moves to acquire Cobalt Power Systems in bid to strengthen distributed energy and storage capabilities
SunPower Corporation signs an LOI to acquire Cobalt Power Systems as it tightens execution and expands storage capabilities. Find out what it means for investors.
American Lithium Minerals strengthens lithium portfolio with strategic 19% interest in Cunningham Mining
American Lithium Minerals acquires a 19% stake in Cunningham Mining. Find out how this strategic move could shape its lithium growth strategy.
Is pelareorep gaining traction? Oncolytics Biotech’s updated GOBLET data draws investor focus to third-line anal cancer
Find out why Oncolytics Biotech’s updated GOBLET cohort 4 data is drawing investor attention to pelareorep’s role in third-line anal cancer.
Intuit TurboTax expands beyond software with NYC flagship debut for AI-enabled in-person tax preparation
Find out how Intuit TurboTax’s NYC flagship blends AI and human expertise to redefine in-person tax filing and reshape its long-term growth strategy.
US Army deepens AI modernization push with enterprise-wide Appian software agreement
Find out how Appian Corporation is supporting the United States Army’s AI-powered modernization strategy and what the enterprise agreement signals for defense technology adoption.
Bitmine Immersion Technologies backs Beast Industries with $200m, expanding its digital infrastructure growth play
Find out how Bitmine Immersion Technologies’ $200 million investment in Beast Industries is reshaping its digital infrastructure growth strategy today.
How elraglusib’s long-term Phase 2 survival data positions Actuate Therapeutics in a difficult pancreatic cancer market
Find out how elraglusib’s long-term Phase 2 survival data is positioning Actuate Therapeutics in the challenging metastatic pancreatic cancer market.
Is a C$16m LIFE offering from ZYUS Life Sciences the catalyst investors are watching in cannabinoid pharma?
ZYUS Life Sciences launches a C$15–16 million LIFE offering to accelerate clinical execution and regulatory readiness. Find out what it means for investors.